Disease | hyperglycemia |
Phenotype | C0271650|glucose intolerance |
Sentences | 8 |
PubMedID- 23376072 | hyperglycemia with glucose intolerance and increases in diabetic markers, glycated albumin and hemoglobin a1c, were significantly induced without affecting body weight gain and food consumption in ld 3:3. |
PubMedID- 23897112 | Design: scores calculated from the consortium to establish a registry for alzheimer's disease (cerad) and braak criteria were correlated with measures of hyperglycemia, hyperinsulinemia, glucose intolerance, and insulin resistance in 197 participants who underwent autopsy after death and who had undergone 2 or more oral glucose tolerance tests (ogtt) using grouped analyses and a continuous mixed-models analysis. |
PubMedID- 25938469 | Alloxan injection lead to glucose intolerance concomitant with fasting hyperglycemia and almost complete loss of insulin response (s1 fig). |
PubMedID- 23466884 | Gdm is a syndrome characterized by glucose intolerance leading to maternal hyperglycemia, endothelial dysfunction, and abnormal regulation of vascular tone [89]. |
PubMedID- 25821506 | The development of glucose intolerance with hyperglycemia, hyperinsulinemia, and markedly increased body weight was observed in long-term consumptions of high fat diet. |
PubMedID- 23203083 | Gdm is a syndrome characterized by glucose intolerance leading to maternal hyperglycemia, endothelial dysfunction, and abnormal regulation of vascular tone [58]. |
PubMedID- 22257465 | hyperglycemia is associated with glucose intolerance and tissue resistance to insulin [82]. |
PubMedID- 24810249 | The diabetic phenotype for avy/a mice, which is characterized by hyperglycemia, hyperinsulinemia, glucose intolerance and insulin resistance, is attained due to constitutive expression of agouti protein driven by the ltr of an intracisternal a particle (iap) inserted in the promoter region of agouti gene [34]. |
Page: 1